Trial intelligence / Profile preview

Glycyrrhizin vs Calcium Hydroxide and Ledermix for Root Canal Disinfection

NCT06453304Phase 3Recruiting

Sponsor
Mansoura University
Start
Mar 2022
Primary completion
Jun 2024
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of glycyrrhizin in apical periodontitis (AP) and pulp necrosis (3 arms), sponsored by Mansoura University. Primary endpoint: Number of colonies forming units of bacterial cells at 7 months. Started Mar 2022; status: recruiting.

02

Drugs

glycyrrhizin
03

Conditions

apical periodontitis (AP)pulp necrosis

Beyond the preview

Go deeper on NCT06453304.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06453304.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call